Litcius/Paper detail

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study

Alexandria M. Doerfler, So Hyun Park, Julia M. Assini, Amer Youssef, Lavanya Saxena, Adam B. Yaseen, Marco De Giorgi, Marcel Chuecos, Ayrea Hurley, Ang Li, Santica M. Marcovina, Gang Bao, Michael B. Boffa, Marlys L. Koschinsky, William R. Lagor

2022Molecular Therapy — Methods & Clinical Development36 citationsDOIOpen Access PDF

Abstract

, and highlights the importance of examining the diverse consequences of CRISPR cutting within repetitive loci and in the genome globally.

Topics & Concepts

CRISPRTransgeneGenetically modified mouseProof of conceptChemistryCell biologyBiologyComputational biologyMolecular biologyBiochemistryComputer scienceGeneOperating systemCRISPR and Genetic EngineeringPluripotent Stem Cells ResearchVirus-based gene therapy research
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study | Litcius